Medrad annual revenues up 9%

Article

Medrad last week announced financial results for its fiscal 1995 (end-January) that saw revenues increase9% and net earnings up as well. The Pittsburgh-based company recordedrevenues for the fiscal year of $78.3 million, compared to $71.7million in the

Medrad last week announced financial results for its fiscal 1995 (end-January) that saw revenues increase9% and net earnings up as well. The Pittsburgh-based company recordedrevenues for the fiscal year of $78.3 million, compared to $71.7million in the prior year. Net earnings in 1995 will be approximately$1.15 per share, compared to 92¢ per share for the same perioda year ago.

Medrad also announced that it has created separate businessunits for its two major businesses, vascular injection systemsand MRI surface coil products. Each unit will have its own dedicatedmanagement team and new product development functions, the companyreported.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.